Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
COMPOUND SERVING AS PDGF RECEPTOR KINASE INHIBITOR, AND COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2021/117846
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a compound having an inhibitory activity against a PDGF receptor kinase. The present invention includes, for example, a compound represented by formula [1] or a pharmaceutically acceptable salt of the compound, or a solvate of the compound. The compound of the present invention has an inhibitory activity against a PDGF receptor kinase. Due to the inhibitory activity thereof against a PDGF receptor kinase, the compound of the present invention is useful as a therapeutic agent for respiratory diseases, cancer, smooth muscle proliferative diseases, vascular proliferative diseases, autoimmune/inflammatory diseases, metabolic diseases, vascular obstructive diseases and the like.

Inventors:
ASADA JUNSHI (JP)
HARUTA YOSHINARI (JP)
YAKUSHIJI HIROYUKI (JP)
TANAKA TORU (JP)
KURAMOTO KAZUYA (JP)
KOSUGI KEIJI (JP)
FUCHIKAMI CHIAKI (JP)
Application Number:
PCT/JP2020/046201
Publication Date:
June 17, 2021
Filing Date:
December 11, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NIPPON SHINYAKU CO LTD (JP)
International Classes:
A61P9/00; A61K31/421; A61K31/426; A61K31/429; A61K31/4365; A61K31/437; A61K31/44; A61K31/4402; A61K31/4406; A61K31/4418; A61K31/4427; A61K31/443; A61K31/4433; A61K31/4439; A61K31/47; A61K31/4965; A61K31/5025; A61K31/505; A61K31/506; A61K31/517; A61K31/519; A61K31/5377; A61K31/5383; A61P9/10; A61P9/12; A61P9/14; A61P11/00; A61P11/06; A61P11/08; A61P17/00; A61P27/02; A61P35/00; A61P35/02; A61P43/00; C07D213/54; C07D213/61; C07D213/73; C07D213/81; C07D215/12; C07D239/14; C07D239/74; C07D241/12; C07D241/20; C07D263/34; C07D277/56; C07D401/04; C07D405/04; C07D409/04; C07D471/04; C07D487/04; C07D495/04; C07D498/04; C07D513/04
Domestic Patent References:
WO2013033620A12013-03-07
WO2013030802A12013-03-07
WO2004089286A22004-10-21
WO2005019220A22005-03-03
WO2005080393A12005-09-01
WO2011090738A22011-07-28
WO2006038100A12006-04-13
Other References:
DATABASE REGISTRY [online] CAS; 13 February 2017 (2017-02-13), XP055835103, retrieved from STN Database accession no. RN 2069836-28-6
REVISED CLINICAL CLASSIFICATION OF PULMONARY HYPERTENSION, 2013
SMOLICH ET AL., BLOOD, vol. 97, pages 1413 - 1421
L. KUERTIB. CZAKO: "Strategic Applications of Named Reactions in Organic Synthesis", 2006, KAGAKU-DOJIN PUBLISHING COMPANY, INC.
ORG. SYNTH., vol. 81, 2005, pages 63 - 76
R. C. LAROCK: "Comprehensive Organic Transformations: A Guide to Functional Group Preparations", 1999, JOHN WILEY SONS, INC.
MARUZEN: "Experimental Chemistry", 1992, article "Chemical Society of Japan"
G. S. ZWEIFELM. H. NANTZ: "Modern Organic Synthesis: An Introduction", 2009, KAGAKU-DOJIN PUBLISHING COMPANY, INC.
SONOGASHIRA ET AL., J, ORGANOMET. CHEM., vol. 653, 2002, pages 46 - 49
NEGISHI ET AL., CHEM. REV., vol. 103, 2003, pages 1979 - 2017
BUCHWALD ET AL., J. AM. CHEM. SOC., vol. 116, 1994, pages 7901 - 7902
BUCHWALD ET AL., ORG. SYNTH., vol. 78, 2002, pages 23 - 28
HARTWIG ET AL., ACC. CHEM. RES., vol. 41, 2008, pages 1534 - 1544
HECK ET AL., J. ORG. CHEM., vol. 37, 1972, pages 2320 - 2322
BELETSKAYA ET AL., CHEM. REV., vol. 100, 2000, pages 3009 - 3066
SUZUKI ET AL., CHEM. REV., vol. 95, 1995, pages 2457 - 2483
"Angew. Chem. Int. Ed.", vol. 50, 2011, pages: 8944 - 8947
CELL, vol. 77, 1994, pages 307 - 316
See also references of EP 4074376A4
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF: